BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1034 related articles for article (PubMed ID: 28681131)

  • 1. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.
    Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H
    Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension.
    Apitz C; Zimmermann R; Kreuder J; Jux C; Latus H; Pons-Kühnemann J; Kock I; Bride P; Kreymborg KG; Michel-Behnke I; Schranz D
    J Am Coll Cardiol; 2012 Jul; 60(2):157-64. PubMed ID: 22766343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.
    Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Apitz C; Hansmann G; Schranz D
    Heart; 2016 May; 102 Suppl 2():ii23-9. PubMed ID: 27053694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
    Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
    J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension].
    Zhang G; Shang X; Deng X; Zhou H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1001-5. PubMed ID: 25623345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease.
    Xi SB; Wang SS; Qian MY; Xie YM; Li JJ; Zhang ZW
    Chin Med J (Engl); 2019 Apr; 132(7):811-818. PubMed ID: 30789367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of high risk factors for patient death and its clinical characteristics on pregnancy associated with pulmonary arterial hypertension].
    Bao Z; Zhang J; Yang D; Xu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):495-500. PubMed ID: 25327730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease.
    Goyal P; Kiran U; Chauhan S; Juneja R; Choudhary M
    Br J Anaesth; 2006 Aug; 97(2):208-14. PubMed ID: 16707530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Kozlik-Feldmann R; Hansmann G; Bonnet D; Schranz D; Apitz C; Michel-Behnke I
    Heart; 2016 May; 102 Suppl 2():ii42-8. PubMed ID: 27053697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.